These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38471680)

  • 1. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
    Wilkinson J; Heal C; Antoniou GA; Flemyng E; Alfirevic Z; Avenell A; Barbour G; Brown NJL; Carlisle J; Clarke M; Dicker P; Dumville JC; Grey A; Grohmann S; Gurrin L; Hayden JA; Heathers J; Hunter KE; Lasserson T; Lam E; Lensen S; Li T; Li W; Loder E; Lundh A; Meyerowitz-Katz G; Mol BW; O'Connell NE; Parker L; Redman BK; Seidler L; Sheldrick KA; Sydenham E; Torgerson D; van Wely M; Wang R; Bero L; Kirkham JJ
    BMJ Open; 2024 Mar; 14(3):e084164. PubMed ID: 38471680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
    Wilkinson J; Heal C; Antoniou GA; Flemyng E; Alfirevic Z; Avenell A; Barbour V; Brown NJL; Carlisle J; Clarke M; Dicker P; Dumville J; Grey A; Grohmann S; Gurrin LC; Hayden JA; Heathers J; Hunter KE; Lasserson T; Lam E; Lensen S; Li T; Li W; Loder E; Lundh A; Meyerowitz-Katz G; Mol BW; O' Connell NE; Parker L; Redman BK; Seidler AL; Sheldrick KA; Sydenham E; Torgerson DJ; van Wely M; Wang R; Bero L; Kirkham JJ
    medRxiv; 2023 Nov; ():. PubMed ID: 37873409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Gillies K; Entwistle V; Treweek SP; Fraser C; Williamson PR; Campbell MK
    Trials; 2015 Oct; 16():484. PubMed ID: 26507504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
    Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing bias in trials from reactions to measurement: the MERIT study including developmental work and expert workshop.
    French DP; Miles LM; Elbourne D; Farmer A; Gulliford M; Locock L; Sutton S; McCambridge J;
    Health Technol Assess; 2021 Sep; 25(55):1-72. PubMed ID: 34553685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant systematic reviews on the same topic in surgery: a study protocol for a meta-epidemiological investigation.
    Katsura M; Kuriyama A; Tada M; Yamamoto K; Furukawa TA
    BMJ Open; 2017 Aug; 7(8):e017411. PubMed ID: 28827269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the reliability, usability, and applicability of AMSTAR, AMSTAR 2, and ROBIS: protocol for a descriptive analytic study.
    Gates A; Gates M; Duarte G; Cary M; Becker M; Prediger B; Vandermeer B; Fernandes RM; Pieper D; Hartling L
    Syst Rev; 2018 Jun; 7(1):85. PubMed ID: 29898777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement on what to measure in randomised controlled trials in burn care: study protocol for the development of a core outcome set.
    Young A; Brookes S; Rumsey N; Blazeby J
    BMJ Open; 2017 Jul; 7(6):e017267. PubMed ID: 28669969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence into practice: protocol for a new mixed-methods approach to explore the relationship between trials evidence and clinical practice through systematic identification and analysis of articles citing randomised controlled trials.
    Byrne BE; Rooshenas L; Lambert H; Blazeby JM
    BMJ Open; 2018 Nov; 8(11):e023215. PubMed ID: 30413510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-value injury care in the adult orthopaedic trauma population: a protocol for a rapid review.
    Bérubé M; Moore L; Leduc S; Farhat I; Lesieur M; Lamontagne J; Pelet S; Berry G; Tardif PA; Côté C; Paquet J
    BMJ Open; 2020 Mar; 10(3):e033453. PubMed ID: 32193261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of recurrent pancreatic cancer after surgical resection: a protocol for systematic review, evidence mapping and meta-analysis.
    Lee JC; Ahn S; Cho IK; Lee J; Kim J; Hwang JH
    BMJ Open; 2018 Apr; 8(4):e017249. PubMed ID: 29632079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review.
    Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L
    BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol.
    Qiu R; Zhong C; Han S; He T; Huang Y; Guan M; Hu J; Li M; Lin Y; Chen J; Shang H
    BMJ Open; 2019 Dec; 9(12):e032256. PubMed ID: 31796484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for the development of a core indicator set for reporting burn wound infection in trials: ICon-B study.
    Davies A; Teare L; Falder S; Coy K; Dumville JC; Collins D; Moore L; Dheansa B; Jenkins ATA; Booth S; Agha R; Shah M; Marlow K; Young A
    BMJ Open; 2019 May; 9(5):e026056. PubMed ID: 31092650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for the development of a core outcome set for cauda equina syndrome: systematic literature review, qualitative interviews, Delphi survey and consensus meeting.
    Srikandarajah N; Noble AJ; Wilby M; Clark S; Williamson PR; Marson AG
    BMJ Open; 2019 May; 9(4):e024002. PubMed ID: 31048424
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.